Literature DB >> 28915102

Acceleration-selective Arterial Spin-labeling MR Angiography Used to Visualize Distal Cerebral Arteries and Collateral Vessels in Moyamoya Disease.

Osamu Togao1, Akio Hiwatashi1, Makoto Obara1, Koji Yamashita1, Kazufumi Kikuchi1, Ryotaro Kamei1, Ataru Nishimura1, Koichi Arimura1, Koji Yoshimoto1, Koji Iihara1, Marc Van Cauteren1, Hiroshi Honda1.   

Abstract

Purpose To evaluate and compare the performance of acceleration-selective arterial spin labeling (AccASL) magnetic resonance (MR) angiography in the visualization of cerebral arteries and collateral vessels in patients with Moyamoya disease with that of time-of-flight (TOF) MR angiography, with digital subtraction angiography (DSA) as the reference standard. Materials and Methods Thirty-six cerebral hemispheres from 22 patients with Moyamoya disease underwent TOF and AccASL MR angiography and DSA. Qualitative evaluations included imaging of the terminal internal carotid artery (ICA), distal middle cerebral arteries (MCAs), Moyamoya vessels, and leptomeningeal anastomosis (LMA) collaterals with reference to DSA. Quantitative evaluations included assessment of contrast-to-noise ratio (CNR) and number of vessels in MCA branches. The linear mixed-effect model was used to compare the two methods. Results Mean scores for qualitative evaluation were significantly higher with AccASL angiography than with TOF angiography for imaging distal MCAs (3.9 ± 0.3 [standard deviation] vs 2.9 ± 1.1; P < .001), Moyamoya vessels (3.6 ± 0.6 vs 2.7 ± 0.9, P < .001), and LMA collaterals (3.8 ± 0.6 vs 1.8 ± 0.7, P < .001). Scores for steno-occlusive degree around the terminal ICAs were better with TOF angiography than with AccASL angiography (2.6 ± 0.5 vs 2.4 ± 0.6, P = .023). CNRs in the M4 segment were significantly higher with AccASL angiography (11.9 ± 12.9, P < .001) than with TOF angiography (4.1 ± 7.9). The number of vessels was significantly higher with AccASL angiography (18.3 ± 5.0, P < .001) than with TOF angiography (8.9 ± 4.9). The increase in the number of vessels from TOF angiography to AccASL angiography was greater in patients with severe ICA steno-occlusion (late ICA stage group, 11.4 ± 4.5; early ICA stage group, 6.8 ± 4.0; P = .007) and well-developed leptomeningeal anastomosis (mildly developed LMA group, 7.1 ± 4.3; well-developed LMA group, 11.3 ± 4.5; P = .011). Conclusion AccASL MR angiography enables better visualization of distal cerebral arteries and collateral vessels in patients with Moyamoya disease than does TOF MR angiography, while TOF MR angiography enables better visualization of stenosis of proximal arteries. Both methods work in a mutually beneficial manner in the assessment of cerebral arteries. © RSNA, 2017 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2017        PMID: 28915102     DOI: 10.1148/radiol.2017162279

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

1.  Improved visualization of superficial temporal artery using segmented time-of-flight MR angiography with venous suppression at 7T.

Authors:  Ning Wei; Zihao Zhang; Jing An; Dehe Weng; Yan Zhuo
Journal:  Neuroradiology       Date:  2018-09-22       Impact factor: 2.804

2.  Validation of Zero TE-MRA in the Characterization of Cerebrovascular Diseases: A Feasibility Study.

Authors:  S Shang; J Ye; W Dou; X Luo; J Qu; Q Zhu; H Zhang; J Wu
Journal:  AJNR Am J Neuroradiol       Date:  2019-09       Impact factor: 3.825

3.  4D ASL-based MR angiography for visualization of distal arteries and leptomeningeal collateral vessels in moyamoya disease: a comparison of techniques.

Authors:  Osamu Togao; Akio Hiwatashi; Makoto Obara; Koji Yamashita; Daichi Momosaka; Ataru Nishimura; Koichi Arimura; Nobuhiro Hata; Koji Yoshimoto; Koji Iihara; Marc Van Cauteren; Hiroshi Honda
Journal:  Eur Radiol       Date:  2018-05-08       Impact factor: 5.315

4.  Vessel-Selective 4D-MRA Using Superselective Pseudocontinuous Arterial Spin-Labeling with Keyhole and View-Sharing for Visualizing Intracranial Dural AVFs.

Authors:  O Togao; M Obara; K Kikuchi; M Helle; K Arimura; A Nishimura; T Wada; H Murazaki; M Van Cauteren; A Hiwatashi; K Ishigami
Journal:  AJNR Am J Neuroradiol       Date:  2022-03-03       Impact factor: 3.825

5.  Acceleration of pCASL-Based Cerebral 4D MR Angiography Using Compressed SENSE: A Comparison With SENSE.

Authors:  Maoxue Wang; Yiming Ma; Fei Chen; Fei Zhou; Jilei Zhang; Bing Zhang
Journal:  Front Neurol       Date:  2022-03-21       Impact factor: 4.003

Review 6.  Neuroimaging at 7 Tesla: a pictorial narrative review.

Authors:  Tomohisa Okada; Koji Fujimoto; Yasutaka Fushimi; Thai Akasaka; Dinh H D Thuy; Atsushi Shima; Nobukatsu Sawamoto; Naoya Oishi; Zhilin Zhang; Takeshi Funaki; Yuji Nakamoto; Toshiya Murai; Susumu Miyamoto; Ryosuke Takahashi; Tadashi Isa
Journal:  Quant Imaging Med Surg       Date:  2022-06

7.  Pointwise encoding time reduction with radial acquisition in subtraction-based magnetic resonance angiography to assess saccular unruptured intracranial aneurysms at 3 Tesla.

Authors:  Qing Fu; Ding-Xi Liu; Xiao-Yong Zhang; Xian-Bo Deng; Chuan-Sheng Zheng
Journal:  Neuroradiology       Date:  2020-08-13       Impact factor: 2.804

Review 8.  Intracranial 3D and 4D MR Angiography Using Arterial Spin Labeling: Technical Considerations.

Authors:  Yuriko Suzuki; Noriyuki Fujima; Matthias J P van Osch
Journal:  Magn Reson Med Sci       Date:  2019-11-22       Impact factor: 2.471

9.  Multi-organ comparison of flow-based arterial spin labeling techniques: Spatially non-selective labeling for cerebral and renal perfusion imaging.

Authors:  Suzanne L Franklin; Isabell K Bones; Anita A Harteveld; Lydiane Hirschler; Marijn van Stralen; Qin Qin; Anneloes de Boer; Johannes M Hoogduin; Clemens Bos; Matthias J P van Osch; Sophie Schmid
Journal:  Magn Reson Med       Date:  2020-11-30       Impact factor: 4.668

10.  Angiographic study of the transdural collaterals at the anterior cranial fossa in patients with Moyamoya disease.

Authors:  Kun Hou; Guichen Li; Yunbao Guo; Baofeng Xu; Kan Xu; Jinlu Yu
Journal:  Int J Med Sci       Date:  2020-07-25       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.